BridgeBio Pharma is dedicated to developing breakthrough medicines for genetic diseases by bridging scientific advancements with commercial viability. The company focuses on treating underserved patient populations through innovative drug development and a commitment to fostering passionate, driven leaders in the field.
Mavericks are sought after for their innovative approach to funding biotech projects through a 'moneyball' model. This role focuses on managing outsourced drug substance manufacturing activities, ensuring quality and regulatory compliance. Calcilytix Therapeutics, a subsidiary of BridgeBio Pharma, is seeking a Sr. Scientist/Associate Director, Drug Substance Development and Manufacturing to lead outsourced manufacturing and contribute to the commercialization of a novel Calcium-Sensing Modulator Encaleret.
BridgeBio Pharma is dedicated to developing breakthrough medicines for genetic diseases by bridging scientific advancements with commercial viability. The company focuses on treating underserved patient populations through innovative drug development and a commitment to fostering passionate, driven leaders in the field.
Superluminal Medicines, Inc.